James Mond - Net Worth and Insider Trading

James Mond Net Worth

The estimated net worth of James Mond is at least $1 Million dollars as of 2024-11-07. James Mond is the EVP, CSO and CMO of ADMA Biologics Inc and owns about 73,174 shares of ADMA Biologics Inc (ADMA) stock worth over $1 Million. Details can be seen in James Mond's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Mond has not made any transactions after 2020-09-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James Mond

To

James Mond Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Mond owns 1 companies in total, including ADMA Biologics Inc (ADMA) .

Click here to see the complete history of James Mond’s form 4 insider trades.

Insider Ownership Summary of James Mond

Ticker Comapny Transaction Date Type of Owner
ADMA ADMA Biologics Inc 2020-09-08 CSO/CMO

James Mond Latest Holdings Summary

James Mond currently owns a total of 1 stock. James Mond owns 73,174 shares of ADMA Biologics Inc (ADMA) as of September 8, 2020, with a value of $1 Million.

Latest Holdings of James Mond

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADMA ADMA Biologics Inc 2020-09-08 73,174 19.72 1,442,991

Holding Weightings of James Mond


James Mond Form 4 Trading Tracker

According to the SEC Form 4 filings, James Mond has made a total of 3 transactions in ADMA Biologics Inc (ADMA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in ADMA Biologics Inc is the acquisition of 4,000 shares on September 8, 2020, which cost James Mond around $8,800.

Insider Trading History of James Mond

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Mond Trading Performance

GuruFocus tracks the stock performance after each of James Mond's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Mond is -2.93%. GuruFocus also compares James Mond's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Mond within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James Mond's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James Mond

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.49 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.2 LIMIT LIMIT LIMIT LIMIT LIMIT

James Mond Ownership Network

Ownership Network List of James Mond

No Data

Ownership Network Relation of James Mond

Insider Network Chart

James Mond Owned Company Details

What does ADMA Biologics Inc do?

Who are the key executives at ADMA Biologics Inc?

James Mond is the CSO/CMO of ADMA Biologics Inc. Other key executives at ADMA Biologics Inc include director & President and CEO Adam S Grossman , EVP & CFO Brian Lenz , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .

ADMA Biologics Inc (ADMA) Insider Trades Summary

Over the past 18 months, James Mond made no insider transaction in ADMA Biologics Inc (ADMA). Other recent insider transactions involving ADMA Biologics Inc (ADMA) include a net sale of 1,486,717 shares made by Adam S Grossman , a net sale of 1,500,000 shares made by Steve Elms , and a net sale of 35,000 shares made by Young Kwon .

In summary, during the past 3 months, insiders sold 856,256 shares of ADMA Biologics Inc (ADMA) in total and bought 0 shares, with a net sale of 856,256 shares. During the past 18 months, 5,039,794 shares of ADMA Biologics Inc (ADMA) were sold and 155,000 shares were bought by its insiders, resulting in a net sale of 4,884,794 shares.

ADMA Biologics Inc (ADMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ADMA Biologics Inc Insider Transactions

No Available Data

James Mond Mailing Address

Above is the net worth, insider trading, and ownership report for James Mond. You might contact James Mond via mailing address: 65 Commerce Way, Hackensack Nj 07601.